Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRO19622 in Non-Alcoholic Steatohepatitis (NASH)
NCT00666016Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olesoxime in Nonalcoholic steatohepatitis (NASH), sponsored by Roche. Started Apr 2008; status: completed.
02
Drugs
olesoxime
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00666016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666016.